JPMorgan Healthcare Leaders ETF (JDOC)

Assets	$11.17M
Expense Ratio	0.65%
PE Ratio	21.88
Shares Out	200,000
Dividend (ttm)	$0.51
Dividend Yield	0.93%
Ex-Dividend Date	Dec 16, 2025
Payout Frequency	Semi-Annual
Payout Ratio	20.66%

Volume	742
Open	55.29
Previous Close	55.10
Day's Range	54.92 - 55.29
52-Week Low	47.67
52-Week High	59.69
Beta	0.50
Holdings	68
Inception Date	Nov 1, 2023

About JDOC

Fund Home Page

The JPMorgan Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation. JDOC was launched on Nov 1, 2023 and is issued by JPMorgan Chase.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: JDOC
• ETF Provider: JPMorgan Chase

Top 10 Holdings

45.91% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	6.98%
AbbVie Inc.	ABBV	6.73%
UnitedHealth Group Incorporated	UNH	6.35%
Johnson & Johnson	JNJ	4.68%
AstraZeneca PLC	AZN	4.43%
Merck & Co., Inc.	MRK	4.34%
Bristol-Myers Squibb Company	BMY	3.37%
Thermo Fisher Scientific Inc.	TMO	3.12%
CVS Health Corporation	CVS	2.97%
Intuitive Surgical, Inc.	ISRG	2.94%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 16, 2025	$0.5121	Dec 18, 2025
Dec 24, 2024	$0.3276	Dec 27, 2024
Dec 16, 2024	$2.48902	Dec 18, 2024
Dec 19, 2023	$0.07965	Dec 22, 2023

Performance

JDOC had a total return of 10.30% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.47%.